SwitchGear Genomics announces distribution agreement with Cosmo Bio

June 1st, 2011 SwitchGear agreement with Cosmo Bio will allow broader exposure in Japan MENLO PARK, Calif. – June, 2011 – SwitchGear Genomics Inc., a leading provider of products for studying the regulatory elements in the human genome, today announced that the company signed an agreement for Cosmo Bio Co., LTD to distribute the innovative LightSwitch Luciferase Assay System™ in Japan. The system consists of a complete reporter assay solution including a genome-wide collection of human promoter and 3′UTR luciferase reporters and optimized luciferase assay reagents for measuring transcriptional activation and translational efficiency in living cells. “We are pleased to be expanding sales in Japan,” said Nathan Trinklein, Ph.D., CEO and co-founder of SwitchGear Genomics, “our agreement further shows our commitment to providing a full and cost-effective reporter assay solution in rapidly growing markets worldwide.” Under the agreement, Cosmo Bio will promote and sell all components of the LightSwitch Luciferase Assay System in Japan with marketing and technical support from SwitchGear. About SwitchGear Genomics, Inc.: SwitchGear Genomics Inc. is a leading provider of technologically innovative products for studying the regulatory elements in the human genome. The company has developed a comprehensive approach to generate new insights into gene regulatory network, allowing researchers to efficiently screen entire pathways in living cells. SwitchGear was founded in March 2005 by Dr. Richard Myers, Dr. Nathan Trinklein and Dr. Shelley Force Aldred from Stanford University. For more information about SwitchGear, please visit the company’s website at www.switchgeargenomics.com Contact info: Nathan Trinklein, Ph.D. CEO and co-founder of SwitchGear Genomics 650-323-6763